 | Up a level |
Unterlauft, J D; Schawkat, M; Häner, N; Lincke, J; Zinkernagel, M S (2022). [Therapy of malignant glaucoma]. Die Ophthalmologie, 119(11), pp. 1155-1159. Springer 10.1007/s00347-022-01718-z
Zinkernagel, M S; Hornby, S J; MacLaren, R E (2012). Choroidal new vessels in type 1 myotonic dystrophy-related macular dystrophy respond to anti-VEGF therapy. Eye, 26(12), pp. 1595-1596. London: Nature Publishing Group 10.1038/eye.2012.197
Ebneter, Andreas; Wagels, B; Zinkernagel, M S (2009). Non-invasive biometric assessment of ocular rigidity in glaucoma patients and controls. Eye, 23(3), pp. 606-611. Nature Publishing Group 10.1038/eye.2008.47
Zinkernagel, A S; Zinkernagel, M S; Elzi, M V; Genoni, M; Gubler, J; Zbinden, R; Mueller, N J (2008). Significance of Staphylococcus lugdunensis bacteremia: report of 28 cases and review of the literature. Infection, 36(4), pp. 314-21. Heidelberg: Springer-Medizin-Verlag 10.1007/s15010-008-7287-9
